Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | AQST Aquestive Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $4.68 -0.4% | $14.86 -2.5% |
| StockIQ Score | 46D+ Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 46D+ | 13F |
| Fundamental | 51C- | 35F |
| Growth | 26F | 50C- |
| Fair Value | 38F | 38F |
| News | 74B | 50C- |
| Quality | 47D+ | 50C- |
| Risk | 54C- | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Aquestive Therapeutics (AQST) outperforms Ascentage Pharma (AAPG) in technical and investor scores, with 81 versus 18 in technical and 55 versus 37 in investor confidence. However, AAPG shows stronger growth potential at 50 compared to AQST’s 26. Both share equal valuation scores of 38, but AQST’s overall rating is moderate while AAPG is weak.
